Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Florida Medicaid Formulary Exclusions Are Not Final, Bristol Tells Investors

Executive Summary

The exclusion of Pravachol and Plavix from Florida's initial Medicaid formulary should not be considered final, Bristol-Myers Squibb Worldwide Group Medicines President Richard Lane told an investor conference call July 25.

You may also be interested in...



Medicare Rx Benefit Could Help Ignite COX-2 Market – Pharmacia’s Hassan

A Medicare drug benefit could help jump-start the stalled COX-2 inhibitor market, Pharmacia CEO Fred Hassan told analysts during the company's annual investor day in New York City Nov. 28

Medicare Rx Benefit Could Help Ignite COX-2 Market – Pharmacia’s Hassan

A Medicare drug benefit could help jump-start the stalled COX-2 inhibitor market, Pharmacia CEO Fred Hassan told analysts during the company's annual investor day in New York City Nov. 28

Rx Discounts Are “Price Industry Must Pay” For Medicare Benefit – Novartis

Discounts for the elderly will be the "price industry has to pay" for a Medicare prescription drug benefit, Novartis CEO Daniel Vasella predicted during a New York City analysts meeting Oct. 30

Related Content

UsernamePublicRestriction

Register

PS038249

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel